Genetically determined angiotensin converting enzyme level and myocardial tolerance to ischemia

FASEB Journal

Volumn 24, Issue 12, 2010, Pages 4691-4700

  Messadi, Erij ^a   Vincent, Marie Pascale ^a   Griol Charhbili, Violaine ^a   Mandet, Chantal ^a,b   Colucci, Juliana ^a   Krege, John H ^c   Bruneval, Patrick ^a,b,d   Bouby, Nadine ^a   Smithies, Oliver ^e   Alhenc Gelas, François ^a,b,d   Richer, Christine ^a,d,f  

^a CENTRE DE RECHERCHE DES CORDELIERS   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c ELI LILLY AND COMPANY   (United States)

^d ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

^e UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^f UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Genetically modified mice; Kinins; Renin inhibition

Indexed keywords

ALISKIREN; ANGIOTENSIN CONVERTING ENZYME 2; DIPEPTIDYL CARBOXYPEPTIDASE; ICATIBANT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; GENETIC VARIABILITY; HEART INFARCTION; HEART INFARCTION SIZE; HEART PROTECTION; ISCHEMIC PRECONDITIONING; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DETERMINATION; REPERFUSION INJURY;

AMIDES; ANGIOTENSIN I; ANGIOTENSIN II; ANIMALS; APOPTOSIS; BLOOD PRESSURE; BRADYKININ; FUMARATES; HEART; KININS; LUNG; MICE; MICE, MUTANT STRAINS; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PEPTIDYL-DIPEPTIDASE A; RECEPTORS, BRADYKININ; RENIN; REPERFUSION INJURY;

MUS;

EID: 78649738484     PISSN: 08926638     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.10-165902     Document Type: Article

References (44)

1. Erdos, E. G. (1990) Angiotensin I converting enzyme and the changes in our concepts through the years. Lewis, K. Dahl memorial lecture. Hypertension 16, 363-370
2. Cambien, F., Alhenc-Gelas, F., Herbeth, B., Andre, J. L., Rakotovao, R., Gonzales, M. F., Allegrini, J., and Bloch, C. (1988) Familial resemblance of plasma angiotensin-converting enzyme level: the Nancy study. Am. J. Hum. Genet. 43, 774-780
3. Rigat, B., Hubert, C., Alhenc-Gelas, F., Cambien, F., Corvol, P., and Soubrier, F. (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343-1346
4. Danser, A. H., Schalekamp, M. A., Bax, W. A., van den Brink, A. M., Saxena, P. R., Riegger, G. A., and Schunkert, H. (1995) Angiotensin-converting enzyme in the human heart. Effect of the deletion/insertion polymorphism. Circulation 92, 1387-1388
5. Costerousse, O., Allegrini, J., Lopez, M., and Alhenc-Gelas, F. (1993) Angiotensin I-converting enzyme in human circulating mononuclear cells: genetic polymorphism of expression in T-lymphocytes. Biochem. J. 290(Pt. 1), 33-40
6. Alhenc-Gelas, F., and Corvol, P. (2000) Molecular and physiological aspects of angiotensinI-converting enzyme. In Handbook of Physiology, Sec. 7, Vol. 3 (Fray, J. C. S, and Goodman, H., eds) pp. 81-103, American Physiological Society and Oxford University Press, New York
7. Falkenhahn, M., Franke, F., Bohle, R. M., Zhu, Y. C., Stauss, H. M., Bachmann, S., Danilov, S., and Unger, T. (1995) Cellular distribution of angiotensin-converting enzyme after myocardial infarction. Hypertension 25, 219-226
8. Takahashi, N., Hagaman, J. R., Kim, H. S., and Smithies, O. (2003) Minireview: computer simulations of blood pressure regulation by the renin-angiotensin system. Endocrinology 144, 2184-2190
9. Dzau, V. J., Bernstein, K., Celermajer, D., Cohen, J., Dahlof, B., Deanfield, J., Diez, J., Drexler, H., Ferrari, R., van Gilst, W., Hansson, L., Hornig, B., Husain, A., Johnston, C., Lazar, H., Lonn, E., Luscher, T., Mancini, J., Mimran, A., Pepine, C., Rabelink, T., Remme, W., Ruilope, L., Ruzicka, M., Schunkert, H., Swedberg, K., Unger, T., Vaughan, D., and Weber, M. (2001) The relevance of tissue angiotensin-converting enzyme: manifestations in mechanistic and endpoint data. Am J Cardiol. 88, 1L-20L
10. Huang, W., Gallois, Y., Bouby, N., Bruneval, P., Heudes, D., Belair, M. F., Krege, J. H., Meneton, P., Marre, M., Smithies, O., and Alhenc-Gelas, F. (2001) Genetically increased angiotensin I-converting enzyme level and renal complications in the diabetic mouse. Proc. Natl. Acad. Sci. U. S. A. 98, 13330-13334
11. Sayed-Tabatabaei, F. A., Oostra, B. A., Isaacs, A., van Duijn, C. M., and Witteman, J. C. (2006) ACE polymorphisms. Circ. Res. 98, 1123-1133
12. Cambien, F., Poirier, O., Lecerf, L., Evans, A., Cambou, J. P., Arveiler, D., Luc, G., Bard, J. M., Bara, L., Ricard, S., Tiret, L., Amouyel, P., Alhenc-Gelas, F., and Soubrier, F. (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359, 641-644
13. Cambien, F., Costerousse, O., Tiret, L., Poirier, O., Lecerf, L., Gonzales, M. F., Evans, A., Arveiler, D., Cambou, J. P., Luc, G., Rakotovao, R., Ducimetiere, P., Soubrier, F., and Alhenc-Gelas, F. (1994) Plasma level and gene polymorphism of angiotensin-converting enzyme in relation to myocardial infarction. Circulation 90, 669-676 (Pubitemid 24242731)
14. Mattu, R. K., Needham, E. W., Galton, D. J., Frangos, E., Clark, A. J., and Caulfield, M. (1995) A DNA variant at the angiotensin-converting enzyme gene locus associates with coronary artery disease in the Caerphilly Heart Study. Circulation 91, 270-274
15. Samani, N. J., Thompson, J. R., O'Toole, L., Channer, K., and Woods, K. L. (1996) A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction. Circulation 94, 708-712
16. Lindpaintner, K., Pfeffer, M. A., Kreutz, R., Stampfer, M. J., Grodstein, F., LaMotte, F., Buring, J., and Hennekens, C. H. (1995) A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N. Engl. J. Med. 332, 706-711
17. Zintzaras, E., Raman, G., Kitsios, G., and Lau, J. (2008) Angiotensin-converting enzyme insertion/deletion gene polymorphic variant as a marker of coronary artery disease: a meta-analysis. Arch. Intern. Med. 168, 1077-1089
18. Krege, J. H., Kim, H. S., Moyer, J. S., Jennette, J. C., Peng, L., Hiller, S. K., and Smithies, O. (1997) Angiotensin-converting enzyme gene mutations, blood pressures, and cardiovascular homeostasis. Hypertension 29, 150-157
19. Griol-Charhbili, V., Messadi-Laribi, E., Bascands, J. L., Heudes, D., Meneton, P., Giudicelli, J. F., Alhenc-Gelas, F., and Richer, C. (2005) Role of tissue kallikrein in the cardioprotective effects of ischemic and pharmacological preconditioning in myocardial ischemia. FASEB J. 19, 1172-1174
20. Goto, M., Liu, Y., Yang, X. M., Ardell, J. L., Cohen, M. V., and Downey, J. M. (1995) Role of bradykinin in protection of ischemic preconditioning in rabbit hearts. Circ. Res. 77, 611-621
21. Messadi-Laribi, E., Griol-Charhbili, V., Pizard, A., Vincent, M. P., Heudes, D., Meneton, P., Alhenc-Gelas, F., and Richer, C. (2007) Tissue kallikrein is involved in the cardioprotective effect of AT1-receptor blockade in acute myocardial ischemia. J. Pharmacol. Exp. Ther. 323, 210-216
22. Pan, H. L., Chen, S. R., Scicli, G. M., and Carretero, O. A. (2000) Cardiac interstitial bradykinin release during ischemia is enhanced by ischemic preconditioning. Am. J. Physiol. Heart Circ. Physiol. 279, H116-H121
23. Costerousse, O., Allegrini, J., Huang, H., Bounhik, J., and Alhenc-Gelas, F. (1994) Regulation of ACE gene expression and plasma levels during rat postnatal development. Am. J. Physiol. 267, E745-753
24. Bodin, S., Chollet, C., Goncalves-Mendes, N., Gardes, J., Pean, F., Heudes, D., Bruneval, P., Marre, M., Alhenc-Gelas, F., and Bouby, N. (2009) Kallikrein protects against microalbuminuria in experimental type I diabetes. Kidney Int. 76, 395-403
25. Livak, K. J., and Schmittgen, T. D. (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25, 402-408
26. Yang, X. P., Liu, Y. H., Scicli, G. M., Webb, C. R., and Carretero, O. A. (1997) Role of kinins in the cardioprotective effect of preconditioning: study of myocardial ischemia/reperfusion injury in B2 kinin receptor knockout mice and kininogen-deficient rats. Hypertension 30, 735-740
27. Eckle, T., Grenz, A., Kohler, D., Redel, A., Falk, M., Rolauffs, B., Osswald, H., Kehl, F., and Eltzschig, H. K. (2006) Systematic evaluation of a novel model for cardiac ischemic preconditioning in mice. Am. J. Physiol. Heart Circ. Physiol. 291, H2533-H2540
28. Aouam, K., Tissier, R., Bruneval, P., Mandet, C., Berdeaux, A., and Ghaleh, B. (2005) Preconditioning of salvaged myocardium in conscious rabbits with postinfarction dysfunction. Am. J. Physiol. Heart Circ. Physiol. 288, H2763-H2769
29. Menard, J., and Catt, K. J. (1972) Measurement of renin activity, concentration and substrate in rat plasma by radioimmunoassay of angiotensin I. Endocrinology 90, 422-430
30. Pons, S., Griol-Charhbili, V., Heymes, C., Fornes, P., Heudes, D., Hagege, A., Loyer, X., Meneton, P., Giudicelli, J. F., Samuel, J. L., Alhenc-Gelas, F., and Richer, C. (2008) Tissue kallikrein deficiency aggravates cardiac remodelling and decreases survival after myocardial infarction in mice. Eur. J. Heart Fail. 10, 343-351
31. Ludbrook, J. (1994) Repeated measurements and multiple comparisons in cardiovascular research. Cardiovasc. Res. 28, 303-311
32. Tian, B., Meng, Q. C., Chen, Y. F., Krege, J. H., Smithies, O., and Oparil, S. (1997) Blood pressures and cardiovascular homeostasis in mice having reduced or absent angiotensin-converting enzyme gene function. Hypertension 30, 128-133
33. Evangelista, F. S., and Krieger, J. E. (2006) Small gene effect and exercise training-induced cardiac hypertrophy in mice: an Ace gene dosage study. Physiol. Genomics 27, 231-236
34. Tschope, C., Heringer-Walther, S., Koch, M., Spillmann, F., Wendorf, M., Leitner, E., Schultheiss, H. P., and Walther, T. (2000) Upregulation of bradykinin B1-receptor expression after myocardial infarction. Br. J. Pharmacol. 129, 1537-1538
35. Tschope, C., Heringer-Walther, S., Koch, M., Spillmann, F., Wendorf, M., Hauke, D., Bader, M., Schultheiss, H. P., and Walther, T. (2000) Myocardial bradykinin B2-receptor expression at different time points after induction of myocardial infarction. J. Hypertens. 18, 223-228
36. Brown, N. J., Gainer, J. V., Murphey, L. J., and Vaughan, D. E. (2000) Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway. Circulation 102, 2190-2196
37. Oldenburg, O., Qin, Q., Krieg, T., Yang, X. M., Philipp, S., Critz, S. D., Cohen, M. V., and Downey, J. M. (2004) Bradykinin induces mitochondrial ROS generation via NO, cGMP, PKG, and mitoKATP channel opening and leads to cardioprotection. Am. J. Physiol. Heart Circ. Physiol. 286, H468-H476
38. Bergaya, S., Meneton, P., Bloch-Faure, M., Mathieu, E., Alhenc-Gelas, F., Levy, B. I., and Boulanger, C. M. (2001) Decreased flow-dependent dilation in carotid arteries of tissue kallikrein-knockout mice. Circ. Res. 88, 593-599
39. Yang, X. P., Liu, Y. H., Shesely, E. G., Bulagannawar, M., Liu, F., and Carretero, O. A. (1999) Endothelial nitric oxide gene knockout mice: cardiac phenotypes and the effect of angiotensin-converting enzyme inhibitor on myocardial ischemia/reperfusion injury. Hypertension 34, 24-30
40. Xiao, H. D., Fuchs, S., Bernstein, E. A., Li, P., Campbell, D. J., and Bernstein, K. E. (2008) Mice expressing ACE only in the heart show that increased cardiac angiotensin II is not associated with cardiac hypertrophy. Am. J. Physiol. Heart Circ. Physiol. 294, H659-H667
41. Muller, D. N., Bohlender, J., Hilgers, K. F., Dragun, D., Costerousse, O., Menard, J., and Luft, F. C. (1997) Vascular angiotensin-converting enzyme expression regulates local angiotensin II. Hypertension 29, 98-104
42. Sato, M., Engelman, R. M., Otani, H., Maulik, N., Rousou, J. A., Flack, J. E., 3rd, Deaton, D. W., and Das, D. K. (2000) Myocardial protection by preconditioning of heart with losartan, an angiotensin II type 1-receptor blocker: implication of bradykinin-dependent and bradykinin-independent mechanisms. Circulation 102, III346-III351
43. Sun, Y., and Weber, K. T. (1994) Angiotensin II receptor binding following myocardial infarction in the rat. Cardiovasc. Res. 28, 1623-1628
44. Yellon, D. M., Alkhulaifi, A. M., and Pugsley, W. B. (1993) Preconditioning the human myocardium. Lancet 342, 276-277